Financial Performance - First-quarter net sales reached $698 million, a 0.4% increase[1] - Organic net sales increased by 2.1%[18] - Reported diluted EPS was $1.23, while adjusted diluted EPS was $1.45[1] - The company's full-year consolidated net sales guidance is $2.945 - $2.975 billion[42] - The company's full-year adjusted-diluted EPS guidance is $6.15 to $6.35[42] Business Segments - Proprietary Products' Q1 organic net sales increased by 2.4%[33] - High Value Products (HVP) components have grown at a CAGR of 13% in the past 5 years[21] - Annex 1 revenues accounted for approximately 200 basis points of total revenues in Q1[21] - Standard products sales were relatively flat year over year[24] - Contract Manufacturing segment is experiencing growth in GLP-1 auto-injector production, offsetting CGM contract exits[27] Profitability - Gross profit margin was 33.2% compared to 33.1% in the same period last year[29] - Reported operating profit was $107 million, while adjusted operating profit was $125 million[29]